Capri Holdings Ltd vs Guardant Health Inc. Common Stock — how do they compare? Capri Holdings Ltd trades at $14.69 (market cap $1.67B), while Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.22B). The key difference: Guardant Health Inc. Common Stock is far larger — about 13.3× Capri Holdings Ltd's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Capri Holdings Ltd for 41 Days and Guardant Health Inc. Common Stock for 0 Days on average.
| CPRI | GH | |
|---|---|---|
Market Cap | $1.67B | $22.22B |
Volume | 3,722,279 | 1,589,453 |
Sector | Consumer Cyclical | Health |
52-Week High | $27.66 | $187.22 |
52-Week Low | $12.71 | $61.73 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | $2.95B | $22.86B |
Signals from Pluang's Aura AI — not financial advice
CPRI trades at $14.44, down 1.57% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $1.18 billion in 2025, though recent quarters have consistently beaten EPS estimates. Revenue has declined from $5.7 billion in 2022 to $4.44 billion in 2025, but management expects second-half growth driven by brand revitalization efforts at Michael Kors and Jimmy Choo.
The stock presents a mixed outlook with a low P/S ratio of 0.5 and a consensus price target of $20.57 offering potential upside. However, significant risks include persistent revenue declines, high debt levels, and competitive pressures in the luxury sector. Analyst sentiment is divided with 44% buy ratings versus 52% hold, reflecting uncertainty about the turnaround timeline.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →